Clinical trial
A Phase 1b Clinical Trial of UB-312 in Patients With Synucleinopathies
NCT05634876 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1b Clinical Trial of UB-312 in Patients With Synucleinopathies
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 31, 2023
- Completion date
- February 11, 2025
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.